Poly(ethylene oxide)-poly(propylene oxide) block copolymers (Pluronic or """"""""poloxamer"""""""") have been shown to sensitize resistant tumors, resulting in an increase in the cytotoxic activity of anthracyclines by 2 to 3 orders of magnitude. The mechanisms of sensitization are not well understood. The objective of this proposal is to determine the mechanisms through which Pluronic sensitizes the drug resistant cancer cells. Based on preliminary data, the hypothesis being evaluated is that Pluronic causes selective energy depletion in resistant cells, which can affect various drug resistance systems and result in the sensitization of resistant cells. Therefore, by formulating antineoplastic agents with Pluronic, the chemotherapy of resistant tumors could be improved. Using a panel of cell lines, designed to represent the major resistance mechanisms, as in vitro and in vivo tumor models, the specific aims of the proposed studies are to: (1) Characterize the effects of Pluronic block copolymers on ATP levels in resistant and sensitive cells and identify the mechanisms responsible for the energy depletion, (2) Identify drug/Pluronic formulations effective against resistant cancers and determine whether energy depletion induced by Pluronic is responsible for the potentiation of the cytotoxic effects of these drugs in these cells, (3) Determine whether the effects of Pluronic on the energy state of the cell inhibit the functional activity of specific drug resistance mechanisms and whether inhibition of these mechanisms contributes to the potentiated cytotoxic effects in resistant cells (4) Determine what factors are important for the efficient delivery of Pluronic to the tumor cells in vivo and identify mechanisms responsible for enhanced chemotherapy of resistant tumors in animal tumor model.
| Alakhova, Daria Y; Kabanov, Alexander V (2014) Pluronics and MDR reversal: an update. Mol Pharm 11:2566-78 |
| Zhao, Yi; Alakhova, Daria Y; Kabanov, Alexander V (2013) Can nanomedicines kill cancer stem cells? Adv Drug Deliv Rev 65:1763-83 |
| Alakhova, Daria Y; Zhao, Yi; Li, Shu et al. (2013) Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia. PLoS One 8:e72238 |
| Zhao, Yi; Alakhova, Daria Y; Kim, Jong Oh et al. (2013) A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer. J Control Release 168:61-9 |
| Dogan, Aysegul; Yalvac, Mehmet E; Sahin, Fikrettin et al. (2012) Differentiation of human stem cells is promoted by amphiphilic pluronic block copolymers. Int J Nanomedicine 7:4849-60 |
| Batrakova, Elena V; Gendelman, Howard E; Kabanov, Alexander V (2011) Cell-mediated drug delivery. Expert Opin Drug Deliv 8:415-33 |
| Luxenhofer, Robert; Sahay, Gaurav; Schulz, Anita et al. (2011) Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles. J Control Release 153:73-82 |
| Sahay, Gaurav; Alakhova, Daria Y; Kabanov, Alexander V (2010) Endocytosis of nanomedicines. J Control Release 145:182-95 |
| Batrakova, Elena V; Li, Shu; Brynskikh, Anna M et al. (2010) Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release 143:290-301 |
| Nowacek, Ari S; McMillan, JoEllyn; Miller, Reagan et al. (2010) Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics. J Neuroimmune Pharmacol 5:592-601 |
Showing the most recent 10 out of 34 publications
